Efficacy and safety of oral deferasirox treatment for transfusional iron overload in pure red cell aplasia patients after allogeneic stem cell transplantation

Ann Hematol. 2019 Jul;98(7):1781-1783. doi: 10.1007/s00277-019-03717-8. Epub 2019 May 22.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Oral
  • Adolescent
  • Adult
  • Aged
  • Allografts
  • Child
  • Deferasirox / administration & dosage*
  • Disease-Free Survival
  • Erythrocyte Transfusion / adverse effects*
  • Female
  • Follow-Up Studies
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Iron Overload* / drug therapy
  • Iron Overload* / etiology
  • Iron Overload* / mortality
  • Male
  • Middle Aged
  • Red-Cell Aplasia, Pure* / mortality
  • Red-Cell Aplasia, Pure* / therapy
  • Survival Rate

Substances

  • Deferasirox